Abstract
Appropriate surgery, followed by radiotherapy when needed, represents the best therapeutic approach to prevent the recurrences of the disease. Tumor size (cT3/cT4), tumors with high-grade histology, lymph node metastases, extraparenchymal extension, neural invasion, lymphatic or vascular invasion, and close (<1 mm) or positive resection margins lead to a worse prognosis and to a high risk of local recurrence. Patterns of recurrence are heterogeneous. Histological confirmation and a complete restaging of the disease including a head and neck MRI and a total body CT scan should be always advised before planning surgery for local/regional recurrences. An aggressive treatment including surgery is oncologically sound with a 5-year disease-free survival of 64.1%.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Merdad M, Richmon JD, Quon H. Management of recurrent malignant salivary neoplasms. Adv Otorhinolaryngol. 2016;78:168–74.
Gllespie MB, Albergotti WG, Eisele DW. Recurrent salivary gland cancer. Curr Treat Options in Oncol. 2012;13:58–70.
Hirvonen K, Back L, Saarilahti K, Leivo I, Hagstrom J, Makitie AA. Pattern of recurrent disease in major salivary gland adenocystic carcinoma. Virchows Arch. 2015;467:19–25.
Wan der Val J, Becking AG, Snow GB, Van der Waal I. Distant metastases of adenoid cystic carcinoma of the salivary glands and the value of diagnostic examination during follow-up Head Neck. 2002;24:779–83.
Kobajashi K, Nakao K, Yoshida M, Ando M, Ebihara Y, Asakage T, Yamasoba T. Recurrent cancer of the parotid gland. How well does salvage surgery work for locoregional failure? ORL J Otorhinolaryngol Relat Spec. 2009;71:239–43.
Huawei L, Wen W, Huang H, Liang Y, Tan X, Liu S, Liu C, Hu M. Recurrent Pleomorphic adenoma of the parotid gland: Intraoperative facial monitoring during parotidectomy. Otolaryngol Head Neck Surg. 2014;15:87–91.
Sood AJ, Houlton JJ, Nguyen AS, Gillespie MB. Facial nerve monitoring during parotidectomy: a systematic review and meta-analysis. Otolaryngol Head Neck Surg. 2015;152:631–7.
Chen AM, Garcia J, Granchi PJ, Johnson J, Eisele DW. Late recurrence from salivary gland cancer: when does ‘cure’ mean cure? Cancer. 2008;112:340–4.
Park CG, Roh JL, Cho KJ, Jin MH, Choi SH, Nam SY, Kim SY. Incidence and risk factors of late recurrence in patients with salivary gland cancer. Clin Otolaryngol. 2017;42:416–24.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Guzzo, M. (2019). Surgical Management of Recurrent Disease. In: Licitra, L., Locati, L. (eds) Salivary Gland Cancer. Springer, Cham. https://doi.org/10.1007/978-3-030-02958-6_8
Download citation
DOI: https://doi.org/10.1007/978-3-030-02958-6_8
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-02957-9
Online ISBN: 978-3-030-02958-6
eBook Packages: MedicineMedicine (R0)